CN105106420A - Antineoplastic traditional Chinese medicine preparation - Google Patents
Antineoplastic traditional Chinese medicine preparation Download PDFInfo
- Publication number
- CN105106420A CN105106420A CN201510454971.8A CN201510454971A CN105106420A CN 105106420 A CN105106420 A CN 105106420A CN 201510454971 A CN201510454971 A CN 201510454971A CN 105106420 A CN105106420 A CN 105106420A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- medicine preparation
- antineoplastic
- traditional chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
An antineoplastic traditional Chinese medicine preparation comprises, by weight, 2 to 2.5 parts of gen-seng, 3 to 4 parts of coptis, 3.5 to 4.5 parts of scorpion, 0.8 to 1.2 parts of toad, 4 to 6 parts of Chinese ilex, 9 to 11 parts of solanumnigrum, 4.5 to 5.5 parts of Rhamnus davurica Pall, and 4.5 to 5.5 parts of rehmannia. The antineoplastic traditional Chinese medicine preparation has significant curative effect on tumour, high cure rate, short treatment period, fast curative effect and low cost.
Description
Technical field
The invention belongs to a kind of Chinese medicine preparation, particularly a kind of anti-tumor disease Chinese medicine preparation.
Background technology
At present, traditional western medical treatment means for tumor are mainly excised, then radiotherapy or chemotherapy is carried out, cancer patient's therapeutic effect for morning, mid-term is better, but do not have obvious therapeutic effect for patient with advanced cancer, therapeutic process is very long, painful simultaneously, patient is damaged very large, and somewhat expensive; And the traditional Chinese medical science adopts expectant treatment means, namely take anti-tumor agents, the existing large multipair early stage cancer patient of various anti-tumor Chinese herbal preparation commercially provided has certain therapeutic effect, but not obvious for middle and terminal cancer patient curative effect.
Summary of the invention
The object of this invention is to provide a kind of anti-tumor disease Chinese medicine preparation, have significant curative effect to tumor disease, cure rate is high, and the cycle of taking is short, and curative effect is fast, and expense is low.
Technical scheme provided by the invention is as follows: a kind of material composition and part by weight of anti-tumor disease Chinese medicine preparation are as follows:
Radix Ginseng 2-2.5,
Rhizoma Coptidis 3-4,
Scorpio 3.5-4.5,
Bufo siccus 0.8-1.2,
Ilicis Purpureae 4-6,
Herba Solani Nigri 9-11,
Fructus rhamni (Rhamnus davurica Pall.) 4.5-5.5,
Radix Rehmanniae 4.5-5.5.
Preparation method: each starting material with water is soaked 12 hours, then dries, be ground into 80 order medicated powder by weight proportion, mix homogeneously becomes powder, or technique makes capsule, honeyed pill routinely.
Effect of above-mentioned raw material of Chinese medicine:
Radix Ginseng: have strongly invigorating primordial QI, multiple arteries and veins takes off admittedly, invigorating the spleen to benefit the lung, promoting the production of body fluid to quench thirst, the effect of Fructus Alpiniae Oxyphyllae of calming the nerves.Cure mainly that impairment caused by overstrain is deficient, food told in lack of appetite, asthenia, regurgitation, stool lingering diarrhea, empty cough with asthma are short, spontaneous perspiration sudden collapse, palpitation with fear, forgetful, dizziness and headache, sexual impotence, frequent micturition, quench one's thirst, woman uterine bleeding, children's's intermittent infantile convulsion and prolonged deficiency be multiple, the disease of all qi-blood-body fluid deficiencies.
Rhizoma Coptidis: have dampness, eliminating fire and detoxication, eliminates effect of carbuncle furuncle, is used for the treatment of the diseases such as damp and hot feeling of fullness, unconsciousness due to high fever, hyperactivity of heart-fire, too fat to move furuncle, feeling of fullness vomiting, incoordination between the liver and stomach.
Scorpio: there is endogenous wind stopping spasmolytic, dispersing pathogen accumulation, removing obstruction in the collateral to relieve pain, blood vessel dilating, the effect reduced blood pressure, is used for the treatment of that tic spasm, middle air port are askew, hemiplegia, tetanus, rheumatoid arthritis stubborn, the diseases such as skin infection, scrofula, tuberculous lymphadenitis, acute tonsillitis and burn.Obvious inhibitory action is had to tumor growth.
Bufo siccus: have detoxicating and resolving stagnation of pathogens, removing food stagnancy diuretic, destroying parasites for curing malnutrition, strengthens myocardial contraction, increases cardiac output, lowers heart rate and eliminates edema and dyspneic function, strengthens immune system and blood circulation.Be used for the treatment of the diseases such as furuncle is sternly swollen, all sores, main dysentery cellulitis, furuncle, carbuncle on the back, scrofula, the lump in the abdomen hypochondriac lump, expansion edema, have antitumor action.
Ilicis Purpureae: there is wind and enrich blood, tonify deficiency, the strong muscle of tonifying liver, effect of reinforcing the kidney to strengthen the bone.For diseases such as dispelling the wind and dampness pathogens arthralgia pain, hemorrhoid.
Herba Solani Nigri: have heat-clearing and toxic substances removing, invigorates blood circulation, detumescence, diuresis anti-inflammatory effect.For controlling furuncle, carbuncle, erysipelas, osteopatia sprain, chronic tracheitis, acute nephritis, skin eczema, prostatitis, dysentery, carninomatosis.
Fructus rhamni (Rhamnus davurica Pall.): have YIN nourishing, supports kidney, invigorates blood circulation, clearing away heat-damp and promoting diuresis, eliminating stagnated food and killing intestinal worms effect.Treat the diseases such as all skin ulcer cold and heat, variola are blackly ruined, swollen abdominal distention, edema abdominal distention, hernia abdominal mass, scrofula, scabies.
Radix Rehmanniae: there is spleen reinforcing, improving eyesight the kidney invigorating, heat clearing away promote the production of body fluid, yin nourishing removing heat from blood, effect of hemostasis.Be used for the treatment of calentura crimson tongue excessive thirst, yin asthenia generating intrinsic heat, hectic fever due to YIN-deficiency consumptive fever, interior-heat are quenched one's thirst, spit blood, epistaxis, send out the diseases such as speckle dermexanthesis.There is obvious immunoregulatory activity function.
Good effect of the present invention: have significant curative effect to tumor disease, cure rate is high, and the cycle of taking is short, and curative effect is fast, and expense is low.
Detailed description of the invention
Embodiment 1
Material composition and part by weight as follows:
Radix Ginseng 2,
Rhizoma Coptidis 3.2,
Scorpio 3.5,
Bufo siccus 0.8,
Ilicis Purpureae 5,
Herba Solani Nigri 9,
Fructus rhamni (Rhamnus davurica Pall.) 4.5,
Radix Rehmanniae 4.5.
Preparation method: each starting material with water is soaked 12 hours, then dries, be ground into 80 order medicated powder by weight proportion, mix homogeneously becomes powder, or technique makes capsule, honeyed pill routinely.
Embodiment 2
Material composition and part by weight as follows:
Radix Ginseng 2.2,
Rhizoma Coptidis 3.5,
Scorpio 4.5,
Bufo siccus 1.2,
Ilicis Purpureae 4,
Herba Solani Nigri 9,
Fructus rhamni (Rhamnus davurica Pall.) 4.8,
Radix Rehmanniae 4.7.
Preparation method is the same.
Embodiment 3
Material composition and part by weight as follows:
Radix Ginseng 2,
Rhizoma Coptidis 3,
Scorpio 4,
Bufo siccus 1,
Ilicis Purpureae 5,
Herba Solani Nigri 10,
Fructus rhamni (Rhamnus davurica Pall.) 5,
Radix Rehmanniae 5.
Preparation method is the same.
Embodiment 4
Material composition and part by weight as follows:
Radix Ginseng 2,
Rhizoma Coptidis 4,
Scorpio 4.1,
Bufo siccus 1.2,
Ilicis Purpureae 6,
Herba Solani Nigri 11,
Fructus rhamni (Rhamnus davurica Pall.) 5.2,
Radix Rehmanniae 5.5.
Preparation method is the same.
Embodiment 5
Material composition and part by weight as follows:
Radix Ginseng 2.3,
Rhizoma Coptidis 3.8,
Scorpio 4,
Bufo siccus 1,
Ilicis Purpureae 5,
Herba Solani Nigri 10,
Fructus rhamni (Rhamnus davurica Pall.) 5,
Radix Rehmanniae 5.1.
Preparation method is the same.
Instructions of taking: every agent 50 grams, every day takes potion, (medicine) being taken before meal use, sends into when taking with warm yellow wine, and diaphoresis after clothes, until go out.Because directly sent into by medicine in the blood of circulation through yellow wine, and cancerous cell is killed in circulation in vivo, is excreted by toxin, Be very effective, no pain sense by perspiration.
Within five days, be a course for the treatment of, early stage patient 1-2 course for the treatment of; More than 4 courses for the treatment of of middle and advanced stage patient.
As follows through 50 routine clinical trial information summaries:
Pulmonary carcinoma, hepatocarcinoma, the brain cancer, bladder cancer, breast carcinoma, gastric cancer and benign tumors is suffered from patient; Early stage patient 8 example is made a definite diagnosis, middle and advanced stage patient 40 example through examination in hospital; Max age 75 years old, minimal ages 48 years old.Benign tumor 2 example.
Take checking: after early stage patient and benign tumor patient take 1-2 the course for the treatment of (5 days courses for the treatment of), cure rate reaches 100%, middle and advanced stage patient takes 4-8 the course for the treatment of (5 days courses for the treatment of) cure rate and reaches 70%, effective percentage 25%, inefficiency 5%.
Example 1: patient is in Mr. Ma, 68 years old, dizzy dimmed at the beginning of 2015, being diagnosed as lung neoplasms surgery through Shenyang ground force Zong Yuan is the cerebral tumor, is patients with terminal, because tumor length cannot be performed the operation at cerebellum privileged sites, therefore radiotherapy in the treatment can only be passed through, aggravation after radiotherapy, can only lie up, and abandons further radiotherapy, after take two courses for the treatment of of this medicament after, symptom significantly takes a turn for the better, and can go out to walk about, and proves tumor atrophy by examination in hospital.
Embodiment 2: patient is in Mrs Liu, 35 years old, in Hospital Physical Examination, within 2011, find that right breast has lump, make a definite diagnosis a tumor 22mm × 18mm, suggestion is excision at once, in case canceration, but patient fears operation, do not carry out excision, adopt and take a course for the treatment of of this medicament, after hospital checks, show tumor disappearance.
Embodiment 3: patient, in maid of honour scholar, 55 years old, finds that left breast has lump, checks to tumour hospital of Liaoning Province for 2010, being diagnosed as malignant tumor, is middle and advanced stage, and patient is to operative treatment and chemotherapy self-distrust, 6 courses for the treatment of of this medicament are taken in employing, and the continuous atrophy of tumor, closely disappears.
Example 4: patient Zhao Xiansheng, 66 years old, 2009, is diagnosed as bladder cancer through tumour hospital of Liaoning Province, and be transfer in late period, can not perform the operation, adopt after taking 8 courses for the treatment of of this medicament, symptom disappears completely, recovery from illness, orthobiosis.
Claims (1)
1. an anti-tumor disease Chinese medicine preparation, it is characterized in that material composition and part by weight as follows:
Radix Ginseng 2-2.5,
Rhizoma Coptidis 3-4,
Scorpio 3.5-4.5,
Bufo siccus 0.8-1.2,
Ilicis Purpureae 4-6,
Herba Solani Nigri 9-11,
Fructus rhamni (Rhamnus davurica Pall.) 4.5-5.5,
Radix Rehmanniae 4.5-5.5.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510454971.8A CN105106420A (en) | 2015-07-30 | 2015-07-30 | Antineoplastic traditional Chinese medicine preparation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510454971.8A CN105106420A (en) | 2015-07-30 | 2015-07-30 | Antineoplastic traditional Chinese medicine preparation |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105106420A true CN105106420A (en) | 2015-12-02 |
Family
ID=54654697
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510454971.8A Pending CN105106420A (en) | 2015-07-30 | 2015-07-30 | Antineoplastic traditional Chinese medicine preparation |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105106420A (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101284052A (en) * | 2007-08-29 | 2008-10-15 | 北京星昊医药股份有限公司 | Chinese medicinal materials compound prescription for treating the tumor |
CN101854919A (en) * | 2007-08-24 | 2010-10-06 | 斯蒂廷海特盖格荷兰协会 | Compositions for the treatment of neoplastic diseases |
CN101869667A (en) * | 2009-04-21 | 2010-10-27 | 苏尔云 | Chinese herbal medicinal composition for treating lung cancer |
-
2015
- 2015-07-30 CN CN201510454971.8A patent/CN105106420A/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101854919A (en) * | 2007-08-24 | 2010-10-06 | 斯蒂廷海特盖格荷兰协会 | Compositions for the treatment of neoplastic diseases |
CN101854919B (en) * | 2007-08-24 | 2012-02-15 | 斯蒂廷海特盖格荷兰协会 | Compositions for the treatment of neoplastic diseases |
CN101284052A (en) * | 2007-08-29 | 2008-10-15 | 北京星昊医药股份有限公司 | Chinese medicinal materials compound prescription for treating the tumor |
CN101869667A (en) * | 2009-04-21 | 2010-10-27 | 苏尔云 | Chinese herbal medicinal composition for treating lung cancer |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102671129B (en) | Traditional Chinese medicine compound for treating cervical cancer | |
CN104225138A (en) | Traditional Chinese medicine for treating bedsore through oral administration and external washing and preparation method of traditional Chinese medicine | |
CN105194542A (en) | Bruise medicinal liquor | |
CN104544436B (en) | A kind of health promoting beverage | |
CN104906465A (en) | Traditional Chinese medicine blood-stasis dispersing composition for treating woman chronic pelvic inflammation and preparation method thereof | |
CN101856446B (en) | Chinese medicinal composition for treating costalgia | |
CN101700372B (en) | Oral medicament for treating chronic pelvic inflammation | |
CN103432539B (en) | Chinese herbal preparation for dispelling damp-heat and damp-toxin | |
CN103405679A (en) | Traditional Chinese medicine composite used for treating herpes zoster | |
CN103191203A (en) | Medicine for treatment of cancer intestinal obstruction and preparation method thereof | |
CN105106420A (en) | Antineoplastic traditional Chinese medicine preparation | |
CN105999092A (en) | Traditional Chinese medicine pill for treating melanosis coli | |
CN105816813A (en) | Medicine composition for treating breast cancer and preparing method and application of medicine composition | |
CN104208530A (en) | Traditional Chinese medicine preparation for treating infantile henoch-schonlein purpura nephritis | |
CN104258206A (en) | Traditional Chinese medicine preparation for treating acute glomerulonephritis | |
CN101204455B (en) | Chinese traditional medicine preparation for curing varicocele | |
CN105770293A (en) | Oral traditional Chinese medicine preparation for treating fever | |
CN105343410A (en) | Tincture for treating acute ankle injury of basketball players and preparation method thereof | |
CN103623378B (en) | Traditional Chinese medicine for treating thoraco-abdominal aorta type multiple aorto-arteritis | |
CN104383418A (en) | Traditional Chinese medicine medicated diet formula for conditioning and nourishing after leukemia chemotherapy and preparation method thereof | |
CN104352963A (en) | Traditional Chinese medicinal preparation for treating chronic pelvic inflammation and preparation method of traditional Chinese medicinal preparation | |
CN104352858B (en) | A kind of Chinese medicine composition for the treatment of infantile diarrhea | |
CN105641360A (en) | Traditional Chinese medicine for treating myocardial infarction | |
CN104083604A (en) | Traditional Chinese medicine for treating fire toxin-type macules | |
CN103550626B (en) | A kind of Chinese medicine preventing large bowel neoplasm postoperative recurrence |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20151202 |